Company: CRL
Filing Date: 2025-01-14
Form Type: 8-K
Source: 0001100682-25-000003
Chunk: 3

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-01-14
Form: 8-K
Item: Item 7.01
Chunk 3
---
, financial condition and results of operations may be adversely affected if the products we manufacture and/or test for our customers do not gain market acceptance.”, and “ CDMO services are highly complex and failure to provide quality and timely services to our CDMO customers, could adversely impact our business.” The Company does not undertake, and assumes no obligation and expressly disclaims any duty, to update or revise its forward-looking statements or any of the information contained in this Current Report on Form 8-K, including related to future events or circumstances except as required by law.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                            CHARLES RIVER LABORATORIES INTERNATIONAL, INC.                   
  Date:      January 14, 2025      By:      /s/ Matthew L. Daniel                                            
                                            Matthew L. Daniel, Corporate Senior Vice President,              
                                            General Counsel, Corporate Secretary & Chief Compliance Officer